Cardinal Health, Inc. $CAH Stake Raised by REAP Financial Group LLC

REAP Financial Group LLC boosted its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 390.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 481 shares of the company’s stock after buying an additional 383 shares during the period. REAP Financial Group LLC’s holdings in Cardinal Health were worth $81,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Shell Asset Management Co. raised its holdings in Cardinal Health by 17.4% during the 2nd quarter. Shell Asset Management Co. now owns 22,438 shares of the company’s stock worth $3,770,000 after buying an additional 3,327 shares during the period. KLP Kapitalforvaltning AS raised its holdings in Cardinal Health by 4.0% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after buying an additional 4,400 shares during the period. Prime Capital Investment Advisors LLC raised its holdings in Cardinal Health by 18.4% during the 2nd quarter. Prime Capital Investment Advisors LLC now owns 7,392 shares of the company’s stock worth $1,242,000 after buying an additional 1,150 shares during the period. Valeo Financial Advisors LLC acquired a new stake in Cardinal Health during the 2nd quarter worth about $425,000. Finally, DAVENPORT & Co LLC raised its holdings in Cardinal Health by 28.7% during the 2nd quarter. DAVENPORT & Co LLC now owns 8,592 shares of the company’s stock worth $1,443,000 after buying an additional 1,918 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insider Activity

In other Cardinal Health news, insider Michelle D. Greene sold 13,500 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares of the company’s stock, valued at $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Stephen M. Mason sold 41,575 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 271,676 shares of company stock valued at $40,489,525. Insiders own 0.12% of the company’s stock.

Cardinal Health Stock Performance

NYSE:CAH opened at $157.77 on Thursday. The stock’s 50 day moving average price is $152.03 and its 200 day moving average price is $150.75. Cardinal Health, Inc. has a 52 week low of $106.98 and a 52 week high of $168.44. The company has a market capitalization of $37.48 billion, a P/E ratio of 24.46, a P/E/G ratio of 1.32 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the prior year, the company posted $1.84 earnings per share. The firm’s revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be given a dividend of $0.5107 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a yield of 1.3%. Cardinal Health’s dividend payout ratio is presently 31.63%.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. Evercore ISI cut their price objective on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. Morgan Stanley reiterated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 2nd. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a report on Tuesday, August 12th. Finally, Leerink Partners upped their target price on Cardinal Health from $186.00 to $187.00 and gave the company an “outperform” rating in a report on Monday. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $166.00.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.